Summary
46
Insights
This section hypothesizes why Vico Therapeutics can be a $10 billion dollar company in 10 years, in 10 lines or less.
Vico Therapeutics has a promising RNA modulation platform that addresses genetic diseases with high unmet needs. Their strong leadership, strategic partnerships, and potential breakthrough treatments position them well for significant growth in the biotech industry.
Total funding Amount
$90M
Fundraising History
-
Jan 05 '24 Series B$59M
-
Jul 29 '20 Series A$31M
Investors
-
EQT Life Sciences
Series A -
Ackermans & van Haaren
Series B
-
Droia VenturesSeries A
-
Kurma PartnersSeries A
-
Idinvest PartnersSeries A